-
22nd Century Group Acquires RX Pharmatech, Files U.S. Drug Master File For CBD API, Teams Up With Transo-Pharm
Tuesday, January 24, 2023 - 11:42am | 49522nd Century Group, Inc. (NASDAQ: XXII) announced the acquisition of privately held RX Pharmatech Ltd, a United Kingdom distributor of cannabinoids with 1,276 novel food applications with the U.K. Food Standards Agency (FSA). Terms of the agreement include an up-front payment of $650,000 in cash...